Senores Pharmaceuticals Limited (BOM:544319)

Market Cap	23.37B
Revenue (ttm)	4.18B
Net Income (ttm)	585.60M
Shares Out	n/a
EPS (ttm)	16.12
PE Ratio	39.91
Forward PE	18.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,437
Average Volume	30,402
Open	512.55
Previous Close	515.10
Day's Range	508.00 - 522.35
52-Week Range	440.00 - 664.00
Beta	n/a
RSI	45.91
Earnings Date	May 15, 2025

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally. The company offers tablets, capsules, liquids, dry syrups, oral rehydration solutions, active pharmaceutical ingredients, and critical care injectables, including antibiotics, anti-bacterial, anti-fungal, and blood line. It also exports its products. The company provides consulting and licensing services. Senores Pharmaceuticals Limited was incorporated in 2017 and is based in Ahmedabad, India.

• Industry: Pharmaceutical Preparations
• Founded: 2017
• Employees: 113
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544319

Financial Performance

In 2024, Senores Pharmaceuticals's revenue was 4.18 billion, an increase of 94.62% compared to the previous year's 2.15 billion. Earnings were 585.60 million, an increase of 86.17%.